Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : The Naked Truth - Big Kahuna a Myth -- Ignore unavailable to you. Want to Upgrade?

To: Cynic 2005 who wrote (6708)	9/22/1998 1:35:00 PM
From: Joseph G.	Read Replies (2) \| Respond to of 86076

<<NEW YORK, Sept 22 (Reuters) - Shares of Pfizer Inc. (NYSE:PFE - news) jumped Tuesday on bargain hunting while Schering-Plough Corp. (NYSE:SGP - news) gained on the company's start of Phase III trials of a new formulation of its Claritin antihistamine, analysts said. Pfizer, the New York drug giant best known for its Viagra anti-impotence pill, was up two to 99-5/8 in afternoon trade. Schering-Plough, based in Madison, N.J., was up 2-7/16 to 99-3/4. .............. Gruntal & Co. drug analyst David Saks said Pfizer has also been hurt by continuing publicity about scores of deaths among millions of people who have taken Viagra, many of them elderly people with cardiovascular problems. But Pfizer has defended the safety of the drug, saying the number of deaths was not surprising given the advanced age and numbers of people taking the world's first anti-impotence pill.>> Hey! Now we know why market's going up - we're gonna safe a bundle on social security payments and solve the US deficit problem. Heil Phizer for that! -g-